[HTML][HTML] COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

JD Goldman, PC Robinson, TS Uldrick… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly
variable disease severity and a bimodal course characterized by acute respiratory viral …

A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to …

A Zinellu, AA Mangoni - Expert Review of Clinical Immunology, 2022 - Taylor & Francis
Background and aims Severe manifestations of coronavirus disease 2019 (COVID-19) are
associated with alterations in blood cells that regulate immunity, inflammation, and …

COVID-19 in patients with hematologic malignancies: clinical manifestations, persistence, and immune response

I Gur, A Giladi, YN Isenberg, A Neuberger… - Acta haematologica, 2022 - karger.com
Background: The clinical presentation of coronavirus disease 19 (COVID-19) is the result of
intricate interactions between the novel coronavirus and the immune system. In patients with …

Non-linear relationship between age and subfoveal choroidal thickness in Chinese patients with proliferative diabetic retinopathy

CY Lei, JY Xie, QB Ran… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND No study has investigated the change regularity between age and
subfoveal choroidal thickness (SFCT) in proliferative diabetic retinopathy (PDR). AIM To …

Mechanical ventilation for COVID-19: Outcomes following discharge from inpatient treatment

MJ Butler, JH Best, SV Mohan, JA Jonas, L Arader… - Plos one, 2023 - journals.plos.org
Though mechanical ventilation (MV) is used to treat patients with severe coronavirus
disease 2019 (COVID-19), little is known about the long-term health implications of this …

Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19

JM Michot, V Dozio, J Rohmer… - Journal of Proteome …, 2024 - ACS Publications
Circulating proteomes provide a snapshot of the physiological state of a human organism
responding to pathogenic challenges and drug interventions. The outcomes of patients with …

Prognostic Value of Routine Biomarkers in the Early Stage of COVID-19

A Mihajlović, D Ivanov, B Tapavički, M Marković… - Healthcare, 2023 - mdpi.com
Various biomarkers like certain complete blood cell count parameters and the derived ratios
including neutrophil–lymphocyte ratio are commonly used to evaluate disease severity. Our …

Clinical manifestations of COVID-19 infection and its impact on the outcome in children and adolescents with benign and malignant hematological disease in Egypt: a …

FSE Ebeid, A Mostafa, SM Magdy, HMAE Kader… - Egyptian Pediatric …, 2025 - Springer
Background It is known that viral infections are associated with increased morbidity and
mortality in immunocompromised children. Few reports describe the clinical manifestations …

COVID-19 mortality prediction model, 3C-M, built for use in resource limited settings-understanding the relevance of neutrophilic leukocytosis in predicting disease …

N Agarwal, D Dua, R Sud, M Yadav, A Agarwal… - medRxiv, 2021 - medrxiv.org
In this study, a combination of clinical and hematological information, collected on day of
presentation to the hospital with pneumonia, was evaluated for its ability to predict severity …

[PDF][PDF] COVID-19 in patients with hematological malignancies (HM): clinical manifestations, persistence and immune response

I Gur, A Giladi, Y Nachum Isenberg, A Neuberger… - Acta …, 2022 - scholar.archive.org
Background: The clinical presentation of coronavirus disease 19 (COVID-19) is the result of
intricate interactions between the novel coronavirus (SARS-CoV-2) and the immune system …